The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Non–Small Cell Lung Cancer: Histopathologic Correlates for Texture Parameters at CT
Abstract
PURPOSE: To correlate computed tomographic (CT) texture in non-small cell lung cancer (NSCLC) with histopathologic markers for angiogenesis and hypoxia. MATERIALS AND METHODS: The study was institutional review board approved, and informed consent was obtained. Fourteen patients with NSCLC underwent CT prior to intravenous administration of pimonidazole (0.5 g/m(2)), a marker of hypoxia, 24 hours before surgery. Texture was assessed for unenhanced and contrast material-enhanced CT images by using a software algorithm that selectively filters and extracts texture at different anatomic scales (1.0 [fine detail] to 2.5 [coarse features]), with quantification of the standard deviation (SD) of all pixel values and the mean value of positive pixels (MPP) and uniformity of distribution of positive gray-level pixel values (UPP). After surgery, matched tumor sections were stained for angiogenesis (CD34 expression) and for markers of hypoxia (glucose transporter protein 1 [Glut-1] and pimonidazole). The percentage and average intensity of the tumor stained were assessed. A linear mixed-effects model was used to assess the correlations between CT texture and staining intensity. RESULTS: SD and MPP quantified from medium to coarse texture on contrast-enhanced CT images showed significant associations with the average intensity of tumor staining with pimonidazole (for SD: filter value, 2.5; slope = 0.003; P = .0003). UPP (medium to coarse texture) on unenhanced CT images showed a significant inverse association with tumor Glut-1 expression (filter value, 2.5; slope = -115.13; P = .0008). MPP quantified from medium to coarse texture on both unenhanced and contrast-enhanced CT images showed significant inverse associations with tumor CD34 expression (unenhanced CT: filter value, 1.8; slope = -0.0008; P = .003; contrast-enhanced CT: filter value, 1.8; slope = -0.0006; P = .004). CONCLUSION: Texture parameters derived from CT images of NSCLC have the potential to act as imaging correlates for tumor hypoxia and angiogenesis. SUPPLEMENTAL MATERIAL: http://radiology.rsna.org/lookup/suppl/doi:10.1148/radiol.12112428/-/DC1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., et al. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.205 · Cited by 15,660
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
HIF-1 and tumor progression: pathophysiology and therapeutics
Semenza, G. L. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02317-1 · Cited by 1,060
Ganeshan, B., Panayiotou, E., Burnand, K., Dizdarevic, S., & Miles, K. (2012) · European Radiology · doi:10.1007/s00330-011-2319-8 · Cited by 505
Self-citationVaria, M. A., Calkins-Adams, D. P., Rinker, L. H., Kennedy, A. S., Novotny, D. B., Fowler, W. C., & Raleigh, J. A. (1998) · Gynecologic Oncology · doi:10.1006/gyno.1998.5163 · Cited by 342
Ganeshan, B., Abaleke, S., Young, R. C. D., Chatwin, C. R., & Miles, K. A. (2010) · Cancer Imaging · doi:10.1102/1470-7330.2010.0021 · Cited by 324
Self-citationThe tumor microenvironment and metastatic disease
Lunt, S. J., Chaudary, N., & Hill, R. P. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9182-2 · Cited by 298
Hypoxia and defective apoptosis drive genomic instability and tumorigenesis
Nelson, D. A., Tan, T.-T., Rabson, A. B., Anderson, D., Degenhardt, K., & White, E. (2004) · Genes & Development · doi:10.1101/gad.1204904 · Cited by 281
Miles, K. A., Ganeshan, B., Griffiths, M. R., Young, R. C. D., & Chatwin, C. R. (2009) · Radiology · doi:10.1148/radiol.2502071879 · Cited by 253
Self-citationRole of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapies
Rapisarda, A., & Melillo, G. (2009) · Drug Resistance Updates · doi:10.1016/j.drup.2009.03.002 · Cited by 154
Schutter, H. D., Landuyt, W., Verbeken, E. K., Goethals, L., Hermans, R., & Nuyts, S. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-42 · Cited by 117
Newbold, K. L., Castellano, I. A., Charles-Edwards, E., Mears, D., Sohaib, A., Leach, M. O., Rhys‐Evans, P. H., Clarke, P. M., Fisher, C., Harrington, K. J., et al. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.07.039 · Cited by 88
Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia
Olive, P. L., Durand, R. E., Raleigh, J. A., Luo, C., & Aquino‐Parsons, C. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1489 · Cited by 71
van Baardwijk, A. A. W., Bosmans, G., van Suylen, R. J., van Kroonenburgh, M. J. P. G., Hochstenbag, M. M. H., Geskes, G. G., Lambin, P., & Ruysscher, D. D. (2008) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.02.002 · Cited by 68
Mandeville, H., Ng, Q. S., Daley, F. M., Barber, P. R., Pierce, G., Finch, J., Burke, M. M., Bell, A. G., Townsend, E. R., Kozarski, R., et al. (2012) · Radiology · doi:10.1148/radiol.12111505 · Cited by 50
Self-citationNa, I. I., Byun, B. H., Kang, H. J., Cheon, G. J., Koh, J. S., Kim, C. H., Choe, D. H., Ryoo, B., Lee, J. C., Lim, S. M., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4074 · Cited by 42
Cited by
Machine Learning methods for Quantitative Radiomic Biomarkers
Parmar, C., Grossmann, P., Bussink, J., Lambin, P., & Aerts, H. J. W. L. (2015) · Scientific Reports · doi:10.1038/srep13087 · Cited by 1,019
Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?
Davnall, F., Yip, C. S. P., Ljungqvist, G., Selmi, M., Ng, F., Sanghera, B., Ganeshan, B., Miles, K. A., Cook, G. J., & Goh, V. (2012) · Insights into Imaging · doi:10.1007/s13244-012-0196-6 · Cited by 878
Self-citationCT Texture Analysis: Definitions, Applications, Biologic Correlates, and Challenges
Lubner, M. G., Smith, A. D., Sandrasegaran, K., Sahani, D. V., & Pickhardt, P. J. (2017) · RadioGraphics · doi:10.1148/rg.2017170056 · Cited by 773
Limkin, E. J., Sun, R., Dercle, L., Zacharaki, E. I., Robert, C., Reuzé, S., Schernberg, A., Paragios, N., Deutsch, E., & Ferté, C. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx034 · Cited by 757
CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma
Coroller, T. P., Grossmann, P., Hou, Y., Rios Velazquez, E., Leijenaar, R. T. H., Hermann, G., Lambin, P., Haibe-Kains, B., Mak, R. H., & Aerts, H. J. W. L. (2015) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2015.02.015 · Cited by 695
Metadata
- Authors
- Ganeshan, B., Goh, V., Mandeville, H. C., Ng, Q. S., Hoskin, P. J., & Miles, K. A.
- Venue
- Radiology
- Published
- 2013-01
- Volume
- 266
- Issue
- 1
- Pages
- 326-336
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2147023528
- Cited by
- 447
- References
- 17
- FWCI
- 14.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.